AR026700A1 - CHEMICAL AND INTERMEDIARY PROCESSES - Google Patents
CHEMICAL AND INTERMEDIARY PROCESSESInfo
- Publication number
- AR026700A1 AR026700A1 ARP000106370A ARP000106370A AR026700A1 AR 026700 A1 AR026700 A1 AR 026700A1 AR P000106370 A ARP000106370 A AR P000106370A AR P000106370 A ARP000106370 A AR P000106370A AR 026700 A1 AR026700 A1 AR 026700A1
- Authority
- AR
- Argentina
- Prior art keywords
- chemical
- processes
- propanoyl
- phosphoryl
- manufacture
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000001311 chemical methods and process Methods 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- CKHHBTVKDKKDQK-RHSMWYFYSA-N (4R)-3-[3,5-difluoro-4-[1-[(2S)-2-hydroxy-3-(oxo-lambda5-phosphanylidyne)propanoyl]-3,6-dihydro-2H-pyridin-4-yl]phenyl]-4-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one Chemical compound O1N=C(C=C1)OC[C@H]1N(C(OC1)=O)C1=CC(=C(C(=C1)F)C1=CCN(CC1)C([C@@H](C#P=O)O)=O)F CKHHBTVKDKKDQK-RHSMWYFYSA-N 0.000 abstract 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000006747 infectious mononucleosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Procesos químicos e intermediarios químicos que son utiles en la formacion selectiva de un grupo mono-fosforilo primario (-OPO(OH)2) en un sistema quecontiene un 1,2-diol-propanoilo (HO-CH2CH(OH)-CO)terminal, y procesos químicos e intermediarios quím icos (y procesos para su fabricacion) utiles en particularpara la fabricacion de agentes bacterianos de oxazolidinona anti-Gram positivas que contienen dicha funcionalidad, en particular para la preparacion de 5(R)-Isoxazol-3-iloximetil-3-(4-(1-(2(S) -hidroxi-3-fosforil-propanoil)-1,2,5,6-tetrahidropirid-4-il)-3,5-difluorofenil)oxazolidin-2-ona.Chemical processes and chemical intermediates that are useful in the selective formation of a primary mono-phosphoryl (-OPO (OH) 2) group in a system containing a 1,2-diol-propanoyl (HO-CH2CH (OH) -CO) terminal , and chemical processes and chemical intermediates (and processes for their manufacture) useful in particular for the manufacture of anti-Gram positive oxazolidinone bacterial agents containing such functionality, in particular for the preparation of 5 (R) -Isoxazol-3-yloxymethyl -3- (4- (1- (2 (S) -hydroxy-3-phosphoryl-propanoyl) -1,2,5,6-tetrahydropyrid-4-yl) -3,5-difluorophenyl) oxazolidin-2-one .
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9928499.4A GB9928499D0 (en) | 1999-12-03 | 1999-12-03 | Chemical processes and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026700A1 true AR026700A1 (en) | 2003-02-26 |
Family
ID=10865576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106370A AR026700A1 (en) | 1999-12-03 | 2000-12-01 | CHEMICAL AND INTERMEDIARY PROCESSES |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1237895A2 (en) |
| JP (1) | JP2003515539A (en) |
| KR (1) | KR20020058072A (en) |
| CN (1) | CN1433421A (en) |
| AR (1) | AR026700A1 (en) |
| AU (1) | AU762241B2 (en) |
| BG (1) | BG106728A (en) |
| BR (1) | BR0016087A (en) |
| CA (1) | CA2395052A1 (en) |
| CO (1) | CO5271712A1 (en) |
| CZ (1) | CZ20021912A3 (en) |
| EE (1) | EE200200282A (en) |
| GB (1) | GB9928499D0 (en) |
| HU (1) | HUP0204052A2 (en) |
| IL (1) | IL149641A0 (en) |
| IS (1) | IS6401A (en) |
| MX (1) | MXPA02005396A (en) |
| NO (1) | NO20022605L (en) |
| PL (1) | PL364762A1 (en) |
| SK (1) | SK7862002A3 (en) |
| WO (1) | WO2001040236A2 (en) |
| ZA (1) | ZA200203876B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| GB0113297D0 (en) * | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
| IL160739A0 (en) | 2001-09-11 | 2004-08-31 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
| US7141588B2 (en) | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| AR038536A1 (en) | 2002-02-25 | 2005-01-19 | Upjohn Co | N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES |
| RU2004129276A (en) | 2002-02-28 | 2005-06-10 | Астразенека Аб (Se) | 3-CYCLIC-5- (NITROGEN-CONTAINING 5-MEMBER RING) METHYL-OXAZOLIDININE DERIVATIVES AND THEIR APPLICATION AS ANTIBACTERIAL MEANS |
| AU2003209994A1 (en) | 2002-02-28 | 2003-09-09 | Astrazeneca Ab | Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| JP2005537301A (en) | 2002-08-12 | 2005-12-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N-aryl-2-oxazolidinones and derivatives thereof |
| AR043050A1 (en) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME |
| MXPA05005472A (en) | 2002-11-21 | 2005-07-25 | Pharmacia & Upjohn Co Llc | N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents. |
| PT1656370E (en) | 2003-06-03 | 2012-11-29 | Rib X Pharmaceuticals Inc | Biaryl heterocyclic compounds and methods of making and using the same |
| US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
| US7304050B2 (en) | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
| JP2007514782A (en) | 2003-12-17 | 2007-06-07 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | Halogenated biaryl heterocyclic compounds and methods for making and using the same |
| EP2716647A3 (en) | 2004-02-27 | 2014-08-20 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| EP1904489B1 (en) | 2005-06-08 | 2011-01-26 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of triazoles |
| EP2069339B1 (en) | 2006-09-25 | 2011-05-18 | Wockhardt Research Centre | Substituted piperidinophenyl oxazolidinones |
| US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU753988B2 (en) * | 1998-06-05 | 2002-10-31 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1999
- 1999-12-03 GB GBGB9928499.4A patent/GB9928499D0/en not_active Ceased
-
2000
- 2000-11-24 CO CO00090190A patent/CO5271712A1/en not_active Application Discontinuation
- 2000-11-28 PL PL00364762A patent/PL364762A1/en unknown
- 2000-11-28 CN CN00818735A patent/CN1433421A/en active Pending
- 2000-11-28 EP EP00979764A patent/EP1237895A2/en not_active Withdrawn
- 2000-11-28 IL IL14964100A patent/IL149641A0/en unknown
- 2000-11-28 BR BR0016087-3A patent/BR0016087A/en not_active Application Discontinuation
- 2000-11-28 SK SK786-2002A patent/SK7862002A3/en unknown
- 2000-11-28 HU HU0204052A patent/HUP0204052A2/en unknown
- 2000-11-28 AU AU17156/01A patent/AU762241B2/en not_active Ceased
- 2000-11-28 WO PCT/GB2000/004527 patent/WO2001040236A2/en not_active Ceased
- 2000-11-28 MX MXPA02005396A patent/MXPA02005396A/en unknown
- 2000-11-28 CA CA002395052A patent/CA2395052A1/en not_active Abandoned
- 2000-11-28 KR KR1020027007072A patent/KR20020058072A/en not_active Withdrawn
- 2000-11-28 JP JP2001540991A patent/JP2003515539A/en active Pending
- 2000-11-28 EE EEP200200282A patent/EE200200282A/en unknown
- 2000-11-28 CZ CZ20021912A patent/CZ20021912A3/en unknown
- 2000-12-01 AR ARP000106370A patent/AR026700A1/en unknown
-
2002
- 2002-05-15 ZA ZA200203876A patent/ZA200203876B/en unknown
- 2002-05-20 BG BG106728A patent/BG106728A/en unknown
- 2002-05-28 IS IS6401A patent/IS6401A/en unknown
- 2002-05-31 NO NO20022605A patent/NO20022605L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02005396A (en) | 2002-11-29 |
| WO2001040236A2 (en) | 2001-06-07 |
| PL364762A1 (en) | 2004-12-13 |
| EP1237895A2 (en) | 2002-09-11 |
| CA2395052A1 (en) | 2001-06-07 |
| EE200200282A (en) | 2003-06-16 |
| KR20020058072A (en) | 2002-07-12 |
| CO5271712A1 (en) | 2003-04-30 |
| WO2001040236A3 (en) | 2002-05-10 |
| JP2003515539A (en) | 2003-05-07 |
| GB9928499D0 (en) | 2000-02-02 |
| IL149641A0 (en) | 2002-11-10 |
| HUP0204052A2 (en) | 2003-03-28 |
| IS6401A (en) | 2002-05-28 |
| SK7862002A3 (en) | 2003-02-04 |
| CZ20021912A3 (en) | 2002-08-14 |
| CN1433421A (en) | 2003-07-30 |
| ZA200203876B (en) | 2003-08-15 |
| AU762241B2 (en) | 2003-06-19 |
| AU1715601A (en) | 2001-06-12 |
| NO20022605L (en) | 2002-06-26 |
| BR0016087A (en) | 2002-08-06 |
| NO20022605D0 (en) | 2002-05-31 |
| BG106728A (en) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR026700A1 (en) | CHEMICAL AND INTERMEDIARY PROCESSES | |
| IL139080A0 (en) | Btx inhibitors and methods for their indentification and use | |
| ATE306175T1 (en) | DEVICE FOR TRANSMITTING CHAT MESSAGES AND METHOD THEREOF | |
| FI20001595L (en) | Method, terminal and system for managing multiple mailboxes | |
| SE9604793D0 (en) | New polymorphs | |
| ATE324417T1 (en) | BIOADHESIVE COMPOSITION CONTAINING POLYPHENOLIC PROTEIN | |
| BR9910236A (en) | Method of sending information through a communication network | |
| WO2007133890A3 (en) | System, method and apparatus for determining if data arrived properly in tdm network | |
| ZA200204395B (en) | Selective neurokinin antagonists. | |
| NO20011350L (en) | 4-Carboxyamino Substituted 1,2,3,4-Tetrahydroquinolines as CETP Inhibitors | |
| EP0984947B8 (en) | Oxazolidinone antibacterial agents having a thiocarbonyl functionality | |
| TR200102029T2 (en) | 1-Heterocyclyl substituted diarylamines. | |
| GB2376112B (en) | A system and method for directory services and e-commerce across multi-provider networks | |
| SI1304327T1 (en) | ||
| DE69935339D1 (en) | Protocol for instant messaging | |
| TR199800077T1 (en) | Controlled release paroxetine preparations. | |
| DE69932415D1 (en) | IMMOBILIZED MESSAGE DELIVERY SYSTEM | |
| AU6617596A (en) | Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them | |
| MXPA04012217A (en) | Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems. | |
| ATE240303T1 (en) | 1,2,4-TRIAZOLE-3-THIONE COMPOUNDS | |
| AU6298096A (en) | Clamping device and associated holder | |
| ATE186711T1 (en) | ZEOLITES AND METHOD FOR THE PRODUCTION THEREOF | |
| DE60318838D1 (en) | Method and apparatus for providing messages to the inbox service of a service message | |
| YU18801A (en) | Eletriptan hydrobromide monohydrate | |
| EP1397007A3 (en) | Method and system for co-relating transport packets on different channels using a packet prioritization scheme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |